Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Purpose: To investigate the incidence of non-infectious non-anterior uveitis (NINAU) based on steroid prescriptions recorded in the Korean National Health Insurance Service (KNHIS) database, covering nearly the entire Korean population.
Methods: Data were collected from patients diagnosed with uveitis who visited clinics between 2010 and 2021. Patients categorized as having NINAU prescribed steroids within one month were defined as "true NINAU." We compared the demographics and underlying comorbidities between patients treated with steroids alone and those receiving immunomodulatory therapy (IMT). Additionally, we analysed trends in IMT use.
Results: Among 38 271 patients with NINAU, the average incidence (per 100, 000 persons) was 6.2 (95% confidence interval, 6.1-6.3) increasing from 2010 to 2017 before gradually declining. Incidence rates increased with age. Most patients with NINAU were managed with systemic corticosteroids alone (approximately 89%); however, steroid-sparing IMT use increased from 2010 to 2021. By 2021, nearly one-third of patients treated with IMT required combination regimens, reflecting increased therapeutic complexity in refractory cases.
Conclusion: We estimated the nationwide incidence of NINAU from the KNHIS database by incorporating steroid prescriptions as an additional criterion. These findings could help inform the national impact of NINAU in South Korea and may have implications for other countries.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/09273948.2025.2524587 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Predictors of uveitic macular edema and functional prognostic outcomes: real-life data from the international AIDA Network uveitis registry.
Front Med (Lausanne)
July 2025
Unit of Ophthalmology, Department of Medicine, Surgery, and Neurosciences, University of Siena and Azienda Ospedaliero-Universitaria Senese [European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory, and Autoimmune Diseases (RITA) Center], Siena, Italy.
Objectives: To detect factors capable of predicting the development of macular edema (ME) throughout the disease course in patients affected by non-infectious uveitis (NIU).
Methods: Predictive factors leading to the development of ME were analyzed through regression analysis. The functional impact of ME on best corrected visual acuity (BCVA) was also examined.
Nationwide Trends in the Incidence and Use of Immunosuppressive Therapy for Non-Infectious Non-Anterior Uveitis in South Korea (2010-2021).
Ocul Immunol Inflamm
June 2025
Department of Ophthalmology, Hanyang University Guri Hospital, Guri-city, South Korea.
Purpose: To investigate the incidence of non-infectious non-anterior uveitis (NINAU) based on steroid prescriptions recorded in the Korean National Health Insurance Service (KNHIS) database, covering nearly the entire Korean population.
Methods: Data were collected from patients diagnosed with uveitis who visited clinics between 2010 and 2021. Patients categorized as having NINAU prescribed steroids within one month were defined as "true NINAU.
Secukinumab in refractory non-infectious anterior uveitis.
Front Ophthalmol (Lausanne)
February 2025
Ophthalmology Department, Fundación Jiménez Díaz University Hospital, Madrid, Spain.
Background: Secukinumab is a monoclonal antibody that selectively neutralizes interleukin-17A and has shown efficacy in the treatment of psoriatic arthritis, psoriasis, and axial spondyloarthritis. Its use in non-anterior non-infectious uveitis is controversial, with evidence generally not supporting its effectiveness in these conditions. However, the role of secukinumab in anterior non-infectious uveitis remains unclear.
View Article and Find Full Text PDFBrain MRI White Matter Abnormalities in Pediatric Non-Infectious Uveitis.
Ocul Immunol Inflamm
April 2025
Department of Ophthalmology, University Medical Center Utrecht, Utrecht, The Netherlands.
Article Synopsis
- Childhood chronic non-infectious uveitis (cNIU) is a complex condition that can mimic other diseases, like demyelinating disorders, and this study focuses on the brain MRI findings in affected children.
- A total of 123 children with cNIU were analyzed, revealing that 26.8% exhibited white matter abnormalities (WMA), particularly among those with non-anterior uveitis and more frequently in males.
- The study suggests that while brain MRIs might be beneficial for monitoring cNIU, the clinical implications of the observed WMAs remain unclear, highlighting the need for interdisciplinary assessment and further long-term studies.
Treatment exit options for non-infectious uveitis registry: participant characteristics at 3 years.
Br J Ophthalmol
December 2024
Department of Ophthalmology, University Hospital Bonn, Bonn, Germany
Purpose: The Treatment exit Options For non-infectious Uveitis (TOFU) registry documents disease courses for non-anterior non-infectious uveitis entities with and without treatment to generate more evidence for clinical management recommendations including treatment exit strategies. In this article, we present the participants' baseline characteristics after the first 3 years.
Methods: TOFU is an observational, prospective registry and recruits patients ≥18 years of age with non-anterior non-infectious uveitis with or without a history of previous disease-modifying antirheumatic drugs (DMARDs) treatment.